Current status of liver transplantation for cholangiocarcinoma
from Liver Transplantation
Cholangiocarcinoma (CCA) is the second most common liver cancer, and it is associated with a poor prognosis. CCA can be divided into intrahepatic, hilar, and distal. Despite the subtype, the median survival is 12-24 months without treatment. Liver transplantation (LT) is recognized worldwide as a curative option for hepatocellular carcinoma.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063